Dashboard
Manage Tickers

DSNKYDaiichi Sankyo Company, LTD

N/A


$ -1.38 (-3.65 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 437.97 $ -13.38 (-2.98 %)
DIA $ 386.91 $ -10.32 (-2.6 %)
SPY $ 518.58 $ -15.52 (-2.91 %)
TLT $ 98.76 $ 0.52 (0.53 %)
GLD $ 222.59 $ -2.86 (-1.27 %)
$ 36.38
-- x --
-- x --
-- - --
$ 23.72 - $ 40.95
58,392
na
0
$ 0.62
nm
TBD
na
na ($ 1.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

mercks-q2-earnings-revenue-and-eps-beat-helped-by-strong-keytruda-sales-but-acquisition-costs-bites-into-annual-profit-forecast
Merck's Q2 Earnings: Revenue And EPS Beat ...
07/30/2024 12:45:16

Merck reports Q2 sales of $16.1 billion, a 7% increase YoY, beating estimates. Keytruda sales surged 16% to $7.27 billion. FDA ...

fda-declines-to-approve-merck-daiichi-sankyo-partnered-lung-cancer-drug
FDA Declines To Approve Merck-Daiichi Sank...
06/27/2024 14:13:16

The FDA issued a Complete Response Letter for Daiichi Sankyo and Merck's BLA for patritumab deruxtecan targeting EGFR-mutat...

Core News & Articles
Reported Earlier, Daiichi Sankyo And Astra...
06/03/2024 06:49:46

DESTINY-Breast06 results show Daiichi Sankyo and AstraZeneca's ENHERTU is the first HER2 directed medicine and antibody d...

why-is-astrazeneca-stock-trading-lower-on-tuesday
Why Is AstraZeneca Stock Trading Lower On ...
05/28/2024 18:32:38

AstraZeneca's TROPION-Lung01 phase 3 trial for datopotamab deruxtecan in NSCLC showed OS improvement in nonsquamous patient...

double-good-news-for-astrazenecas-breast-cancer-drugs
Double Good News For AstraZeneca's Breast ...
04/29/2024 13:25:58

Results from AstraZeneca's Enhertu trial vs. chemotherapy in HR-positive, HER2-low metastatic breast cancer.

astrazenecadaiichis-flagship-drug-enhertu-secures-accelerated-fda-approval-for-pretreated-cancer-patients-with-solid-tumor
AstraZeneca/Daiichi's Flagship Drug Enhert...
04/08/2024 14:34:33

FDA approves Daiichi Sankyo's and AstraZeneca's Enhertu for unresectable or metastatic HER2+ solid tumors. Accelerated ...

Core News & Articles
Daiichi Sankyo And AstraZeneca's Datopotam...
04/02/2024 06:18:36

Core News & Articles
Daiichi Sankyo And AstraZeneca Announced E...
02/19/2024 15:56:25

Application based on results from the TROPION-Lung01 phase 3 trial If approved, Daiichi Sankyo and AstraZeneca’s datopotamab de...

Core News & Articles
Daiichi Sankyo And AstraZeneca's Supplemen...
01/29/2024 07:19:05

Application based on results from DESTINY-PanTumor02 trial and supported by additional ENHERTU data Submission to be reviewe...

whats-going-on-with-pfizer-stock-today
What's Going On With Pfizer Stock Today?
01/25/2024 14:26:07

Pfizer to announce Q4 2023 earnings on 30th Jan. Analysts project EPS loss of $(0.22) and $14.25B in revenues.

why-pharmaceutical-company-esperion-therapeutics-shares-are-diving-today
Why Pharmaceutical Company Esperion Therap...
01/03/2024 14:47:39

Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares are trading lower on Wednesday after the company announced a $125 million ame...

Core News & Articles
The FDA Has Accepted And Granted Priority ...
12/22/2023 13:04:05

japan-emerges-as-promising-2024-investment-destination-3-stocks-to-consider
Japan Emerges As Promising 2024 Investment...
12/20/2023 13:38:11

Japanese stocks are gaining favor among I-banks and sport attractive valuations; here are 3 stocks with low P/B that have outpe...

Core News & Articles
Daiichi Sankyo And Merck Announce Collabor...
10/20/2023 07:15:42

Financial Highlights Under the terms of the agreement, Merck will pay Daiichi Sankyo upfront payments of $1.5 billion for ifin...

better-than-chemotherapy---astrazenecadaiichi-sankyo-partnered-cancer-drug-meets-primary-goal-in-breast-cancer-setting
Better Than Chemotherapy - AstraZeneca/Dai...
09/22/2023 11:46:44

AstraZeneca Plc (NASDAQ: AZN) and Daiichi Sankyo (OTC: DSKYF) (OTC: 

Core News & Articles
AstraZeneca- Daiichi Sankyo's Datopotamab ...
09/22/2023 06:54:16

astrazenecas-reinforces-hold-in-lung-cancer-settings-touts-promising-data-from-three-trials
AstraZeneca's Reinforces Hold In Lung Canc...
09/11/2023 13:59:27

Daiichi Sankyo (OTC: DSKYF) (OTC: DSNKY) and AstraZeneca plc (NASDAQ: AZN) released initial results from the TROPION-Lung04 pha...

Core News & Articles
AstraZeneca, Daiichi Sankyo's Datopotamab ...
09/11/2023 08:29:44

The trial included patients with previously untreated advanced or metastatic non-small cell lung cancer (NSCLC) without actiona...

fda-greenlights-daiichi-sankyos-blood-cancer-drug-a-promising-competitor-to-novartis-rydapt
FDA Greenlights Daiichi Sankyo's Blood Can...
07/21/2023 13:44:31

The FDA has approved Daiichi Sankyo's (OTC: DSNKY) Vanflyta (quizartinib) in

psyched-a-100m-donation-pledge-frank-biden-gets-candid-new-search-trends--more
Psyched: A $100M Donation Pledge, Frank Bi...
07/04/2023 14:21:01

World's Largest Psychedelics Conference Boasts 12K Attendees

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION